Some stocks slip back down after hitting record highs. Here are the stocks investors think will continue to soar, USA Today reports.» Read More
NEW YORK— Target's reinvention plan continues. The retailer said Thursday that Kathryn Tesija, who also served as executive vice president, will move temporarily to a strategic adviser role on July 6 and plans to leave the company in April 2016. In a filing with the Securities and Exchange Commission Thursday, Target said that Tesija will continue to receive her...
June 18- Rite Aid Corp on Thursday lowered its full-year profit outlook after reporting worse-than-expected first-quarter earnings hurt by interest costs and taxes related to a pending acquisition. Rite Aid, which sells over-the-counter drugs, personal care items and food and beverages, said total revenue rose 2.8 percent to $6.6 billion, with...
CVS Health Corp. executives say these changes reflect customer demand. The push from CVS reflects similar expansions by rivals Walgreens Boots Alliance Inc. and Rite Aid Corp. into selling healthier foods and more beauty items. "Health and beauty, in particular, is very high profit margin, and CVS has always been a leader there," said Jeff Jonas, a portfolio...
“Mad Money” host Jim Cramer issues a warning to Twitter—bye bye birdie?
"Fast Money" traders discussed how to play CVS' acquisition of Target's pharmacy business and Gap's restructuring plans.
Jim Cramer speaks with both CVS and Target CEOs on the pharmacy partnership announced. Could it provide healthy gains for your portfolio?
Jim Cramer gives a lesson on how the heck Greece is related to Rite Aid, and how to profit from it.
*United Tech falls as it looks to exit helicopter business. June 15- Stocks fell on Wall Street on Monday as investors fretted over the consequences of a possible debt default by Greece, but talk of multi-billion dollar healthcare deals buoyed shares in the sector, cutting into the market's loss. After Sunday's breakdown of the cash-for-reform talks between...
U.S. stocks closed lower as investors remained anxious over stalled Greece debt talks and the upcoming two-day Federal Reserve meeting.
CVS is buying Target's pharmacy business, but the deal shouldn't raise antitrust concerns or prices, NBC News reports.
June 15- Drugstore operator CVS Health Corp said it will acquire Target Corp's U.S. pharmacy and clinics businesses in a $1.9 billion deal that will help it bargain with drug makers for lower prices. "The addition of the Target pharmacy adds significant purchasing clout for pharmaceuticals," FBR Capital markets analyst Steven Halper wrote in a note.
Some of the names on the move ahead of the open.
June 15- Drugstore operator CVS Health Corp said it will acquire Target Corp's U.S. pharmacy and clinics businesses for about $1.9 billion to boost sales and prescription volumes. CVS's shares were up 0.4 percent at $102.65 in premarket trading on Monday, while Target's were flat at $79.50. Barclays is CVS's financial adviser, while Target's is Goldman Sachs.
CVS Health and Target on Monday announced a deal for CVS to acquire Target's pharmacy and clinic businesses for about $1.9 billion.
June 15- Drugstore operator CVS Health Corp said it will acquire Target Corp's pharmacy and clinic businesses for about $1.9 billion.
The middle class is back, and some analysts say it's time to dip into the retail stocks that could benefit the most.
Here are some of the Top Best Most wonderful discounts for seniors.
Regeneron's shares sank 4 percent despite a positive Food and Drug Administration recommendation on a cholesterol drug. What gives?
It's been quiet in the U.S. stock market this year ... too quiet.
*Deal gives Cardinal Health more generic volume. June 5- Cardinal Health Inc said it would buy privately held drug distributor Harvard Drug Group for $1.12 billion to boost volumes of its generic distribution business. The Livonia, Michigan- based Harvard Drug Group, a distributor of generic and over-the-counter drugs, had revenue of about $450 million in 2014,...